Sugi Predict

Sugi Predict / Compounds / SCHEMBL4188670

SCHEMBL4188670

SCHEMBL4188670

Cc1nccn1-c1ccc(C=O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 1.00
▸ MGAM O43451 1/20 0.57
▸ GAA P10253 1/20 0.57
▸ SI P14410 1/20 0.57
▸ MGAM2 Q2M2H8 1/20 0.57
▸ CYP3A4 P08684 3/20 0.51
▸ CYP2D6 P10635 2/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP19A1 P11511 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ CYP2A6 P11509 2/20 0.50
▸ CYP2E1 P05181 1/20 0.50
▸ PDE3B Q13370 2/20 0.47
▸ PDE3A Q14432 2/20 0.47
▸ ADH5 P11766 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ PDE4A P27815 2/20 0.46
▸ PDE4B Q07343 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30558759 0.84 ALDH1A1 (0.71) ALDH1A1MGAMGAASIMGAM2
SCHEMBL25342215 0.80 ALDH1A1 (0.67) ALDH1A1MGAMGAASIMGAM2
SCHEMBL30643047 0.80 ALDH1A1 (0.67) ALDH1A1MGAMGAASIMGAM2
SCHEMBL30305324 0.79 ADH5 (0.66) ALDH1A1MGAMGAASIMGAM2
SCHEMBL8268417 0.79 ALDH1A1 (0.65) ALDH1A1MGAMGAASIMGAM2
SCHEMBL14761942 0.78 ALDH1A1 (0.64) ALDH1A1MGAMGAASIMGAM2
SCHEMBL23884857 0.77 ALDH1A1 (0.62) ALDH1A1CYP2A6KDM4EMAPK1MEN1
SCHEMBL25342975 0.77 ALDH1A1 (0.62) ALDH1A1MGAMGAASIMGAM2
SCHEMBL265184 0.76 ALDH1A1 (0.61) ALDH1A1MGAMGAASIMGAM2
SCHEMBL2048531 0.76 ALDH1A1 (0.61) ALDH1A1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240299400-A1 Transcription Factor GLI1 Inhibitors and Uses Thereof UNIVERSITY OF CONNECTICUT (US) 2024-09-12 — — US disclosed
CN-116940562-A Acetamido-phenylbenzamide derivatives and methods of use thereof 希华医药有限公司 2023-10-24 — — CN disclosed
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 — — WO disclosed
EP-4225745-A1 ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME Athenex, Inc. (US) 2023-08-16 — — EP disclosed
WO-2022076662-A1 ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME ATHENEX, INC. (US) 2022-04-14 — — WO disclosed
US-20220106301-A1 ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME Health Hope Pharma Limited (HK) 2022-04-07 — — US disclosed
US-20190111044-A1 2-PHENETHENYLTETRAHYDRO ISOQUINOLINES USEFUL AS ANTI-HIV COMPOUNDS Prosetta Antiviral, Inc. 2019-04-18 — — US disclosed
US-20190111044-A1 2-PHENETHENYLTETRAHYDRO ISOQUINOLINES USEFUL AS ANTI-HIV COMPOUNDS Prosetta Antiviral, Inc. 2019-04-18 — — US disclosed
US-10195189-B2 2-phenethenyltetrahydro isoquinolines useful as anti-HIV compounds Prosetta Antiviral, Inc. (US) 2019-02-05 — — US disclosed
US-10195189-B2 2-phenethenyltetrahydro isoquinolines useful as anti-HIV compounds Prosetta Antiviral, Inc. (US) 2019-02-05 — — US disclosed
EP-1054005-A1 SULFONAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-11-22 — — EP disclosed
US-5753682-A Imidazole lipoxygenase inhibitors PFIZER INC. (US) 1998-05-19 — — US disclosed
EP-0703913-B1 IMIDAZOLES AS LIPOXYGENASE INHIBITORS PFIZER (US) 1997-06-11 — — EP disclosed
EP-0703913-A1 IMIDAZOLE LIPOXYGENASE INHIBITORS PFIZER (US) 1996-04-03 — — EP disclosed
WO-1994029299-A1 IMIDAZOLE LIPOXYGENASE INHIBITORS PFIZER INC. (US) 1994-12-22 — — WO disclosed
WO-1991017163-A1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY PFIZER INC. (US) 1991-11-14 — — WO disclosed
EP-0090978-B1 IMIDAZOLYLPHENYL-TETRAHYDROPYRIDAZINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM A. Nattermann & Cie. GmbH (DE) 1988-11-30 — — EP disclosed
US-4699914-A CONGESTIVE HEART FAILURE A. NATTERMANN & CIE GMBH (DE) 1987-10-13 — — US disclosed
US-4551455-A HYPOTENSIVE AGENTS A. NATTERMANN & CIE GMBH (DE) 1985-11-05 — — US disclosed
EP-0090978-A2 Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them A. Nattermann & Cie. GmbH (DE) 1983-10-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190111044-A1 2-PHENETHENYLTETRAHYDRO ISOQUINOLINES USEFUL AS ANTI-HIV COMPOUNDS MAVS, EIF2AK2, POLRMT ALDH1A1 3748/4885MGAM 3620/4885GAA 1987/4885
US-20240299400-A1 Transcription Factor GLI1 Inhibitors and Uses Thereof GLI1, GLI2, SHH ALDH1A1 550/4885MGAM 4571/4885GAA 1519/4885
US-10195189-B2 2-phenethenyltetrahydro isoquinolines useful as anti-HIV compounds MAVS, EIF2AK2, POLRMT ALDH1A1 3748/4885MGAM 3620/4885GAA 1987/4885
US-20220106301-A1 ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME ABCB1, ABCC1, UGT2B7 ALDH1A1 102/4885MGAM 671/4885GAA 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.